By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Generex Biotechnology Corporation (GNBT) Provides Data Update From AE37 Phase II Breast Cancer Trial One Year Post Completion Of Enrollment 5/14/2015 7:41:08 AM
Generex Biotechnology Corporation (GNBT) Announces Intention To Dividend A Portion Of Anticipated SMFI Securities To Its Stockholders Upon A Reverse Stock Split 5/4/2015 7:46:23 AM
Generex Biotechnology Corporation (GNBT) Announces New $11 Million Collaboration On Buccal Cannabis 4/23/2015 11:26:26 AM
Generex Biotechnology Corporation (GNBT) Announces Presentation Of Data Correlating Immune Response With Reduction Of Relapse In AE37 Phase II Breast Cancer Trial At AACR 2015 4/21/2015 11:41:32 AM
Generex Biotechnology Corporation (GNBT) Acknowledges the Contributions Of Its Chairman 4/8/2015 6:41:31 AM
Generex Biotechnology Corporation (GNBT) Provides Update On Buccal Insulin Formulation Enhancement Project 3/12/2015 11:25:17 AM
Generex Biotechnology Corporation (GNBT) Provides Update On Antigen Express Phase 2 AE37 Breast Cancer Vaccine Trial 2/17/2015 7:49:53 AM
Generex Biotechnology Corporation (GNBT) Announces Participation In MedCannAccessCannScience Partnership On Non-Smoked Forms Of Marijuana 12/17/2014 10:13:47 AM
Generex Biotechnology Corporation (GNBT) Announces Collaboration On Medicinal Cannabis 11/18/2014 2:31:06 PM
Generex Biotechnology Corporation (GNBT) Announces Presentation At The Society For Immunotherapy Of Cancer Demonstrating That Induction Of Antibody Response In Patients Receiving The AE37 Breast Cancer Vaccine Correlates With Reduced Relapse 11/11/2014 8:56:25 AM
12345678910...
//-->